Optimizing Induction Chemotherapy Regimens for ND Elderly AML Patients Who Are Eligible for Intense Chemotherapy
Clinical trial NCT06066242 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06066242
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2027-10-20
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.